Key Facts of ProBioGen AG
"One-Stop Shop" from Cell Line Development up to GMP Manufacturing and Release-Testing of Biopharmaceutical Drug Substances.
State-of-the-art Services
- Contract Cell Line Development
- Contract Process Development
- Contract Manufacturing (GMP and non-GMP)
- Protein analytics
- Cell-based assays
Technologies
- Proprietary AGE1® designer cell lines for vaccine and glycoprotein manufacturing
- GlymaxX® Elegant Glyco-Engineering to Boost the ADCC Activity of Antibodies
- Innovative Cell Based Assays
- Human Artificial Lymph Node (HuALN) Technology Prediction of immune responses to drug candidates
- CHO platform
- Media platform
- Continuously expanding patent portfolio
Project Management
- Professional by dedicated project manager
- Strictly adhering to timelines
- Strictly adhering to budget
- Including regulatory support
Management Team
- Wieland W. Wolf, PhD, CEO (President of the European Association of Pharma Biotechnology, ex‑Rentschler Biotechnologie GmbH)
- Volker Sandig, PhD, CSO (ex-Merck Inc.)
- Rene Brecht, PhD, VP Process Science and Manufacturing
- Gabriele Schneider, PhD, VP Business Development
Company
- Founded in 1994
- Highly skilled staff; 70 employees
- Located in Berlin, Germany
- 3,600 sqm laboratory and office space
- GMP unit based on disposable bioreactor technology
- Subsidiary company of Minapharm Pharmaceuticals SE, Egypt